Trasylol replaced by Aminocaproic Acid and Tranexamic Acid

1 Star2 Stars3 Stars4 Stars5 Stars (1 votes, average: 5 out of 5)
Loading ... Loading ...

Dr. S. Jacob Scheinerman, a cardiac surgeon at the New Hyde Park hospital, referring to the drug Trasylol, said “We use it minimally at Long Island Jewish, There are other ways to do open heart surgery.” He also said that the hospital still has a supply of Trasylol and he would use it if the situation called for it. Bayer AG, at the request of U.S., German and Canadian health agencies, a German Drug Maker deliberately removed the medication from the market. Dr. Newell Robinson, a cardiac surgeon at St. Francis Hospital in Rosyln said that the hospital’s decision to limit the drug’s use followed a January 2006 study that found increased risks of kidney failure, stroke, heart attack or heart failure among those who took the drug compared with two other drugs and the name of these two are aminocaproic acid and tranexamic acid, both can be used to stop excessive bleeding. Dr. Tim Gardner, president-elect of the American Heart Association, said that Trasylol never has been adopted 100 percent by cardiac surgeons; there are really no other drugs like it. “It is highly effective in certain circumstances.”

Read: newsday.com

Comments are closed.

Close
E-mail It